Guard Therapeutics International AB (publ) (STO:GUARD)

Market Cap	357.98M
Revenue (ttm)	n/a
Net Income (ttm)	-115.77M
Shares Out	20.17M
EPS (ttm)	-9.89
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,963
Average Volume	51,729
Open	17.60
Previous Close	17.75
Day's Range	17.50 - 18.30
52-Week Range	11.85 - 38.17
Beta	-0.20
RSI	59.76
Earnings Date	Aug 19, 2025

About STO:GUARD

Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in October 2019. Guard Therapeutics International AB (publ) was incorporated in 2008 and is ba...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 12
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: GUARD